Spruce Biosciences公司宣布,其针对B型圣菲利波综合征(又称黏多糖贮积症IIIB型,MPS IIIB)的长期Tralesinidase Alfa酶替代疗法数据,已在第18届国际黏多糖贮积症研讨会上正式公布。该数据揭示了该疗法在长期治疗中的表现与潜力。
Spruce Biosciences公司宣布,其针对B型圣菲利波综合征(又称黏多糖贮积症IIIB型,MPS IIIB)的长期Tralesinidase Alfa酶替代疗法数据,已在第18届国际黏多糖贮积症研讨会上正式公布。该数据揭示了该疗法在长期治疗中的表现与潜力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.